Andrea Semplicini

Author PubWeight™ 49.97‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 A prospective study of the prevalence of primary aldosteronism in 1,125 hypertensive patients. J Am Coll Cardiol 2006 3.74
2 Aldosterone and refractory hypertension: a prospective cohort study. Am J Hypertens 2006 1.53
3 Renal vein renin measurements accurately identify renovascular hypertension caused by total occlusion of the renal artery. J Hypertens 2002 1.48
4 Downregulation of the longevity-associated protein sirtuin 1 in insulin resistance and metabolic syndrome: potential biochemical mechanisms. Diabetes 2010 1.48
5 Rosiglitazone reduces glucose-induced oxidative stress mediated by NAD(P)H oxidase via AMPK-dependent mechanism. Arterioscler Thromb Vasc Biol 2007 1.44
6 Abnormal regulation of G protein alpha(i2) subunit in skin fibroblasts from insulin-resistant hypertensive individuals. J Hypertens 2004 1.42
7 Antioxidant effect of L-carnitine and its short chain esters: relevance for the protection from oxidative stress related cardiovascular damage. Int J Cardiol 2006 1.30
8 Intravenous thrombolysis with rt-PA in acute ischemic stroke patients aged older than 80 years in Italy. Cerebrovasc Dis 2007 1.12
9 Metformin prevents glucose-induced protein kinase C-beta2 activation in human umbilical vein endothelial cells through an antioxidant mechanism. Diabetes 2005 1.05
10 In-hospital percentage BNP reduction is highly predictive for adverse events in patients admitted for acute heart failure: the Italian RED Study. Crit Care 2010 1.04
11 Interplay between miR-155, AT1R A1166C polymorphism, and AT1R expression in young untreated hypertensives. Am J Hypertens 2010 1.02
12 Callipeltin A: sodium ionophore effect and tension development in vascular smooth muscle. Biochem Pharmacol 2004 0.99
13 Angiotensin II-stimulated collagen production in cardiac fibroblasts is mediated by reactive oxygen species. J Hypertens 2006 0.99
14 Prospective evaluation of the saline infusion test for excluding primary aldosteronism due to aldosterone-producing adenoma. J Hypertens 2007 0.96
15 Green tea attenuates angiotensin II-induced cardiac hypertrophy in rats by modulating reactive oxygen species production and the Src/epidermal growth factor receptor/Akt signaling pathway. J Nutr 2008 0.93
16 Vitamin C prevents zidovudine-induced NAD(P)H oxidase activation and hypertension in the rat. Cardiovasc Res 2006 0.90
17 Effects of angiotensin II and insulin on ERK1/2 activation in fibroblasts from hypertensive patients. Am J Hypertens 2004 0.89
18 Increased expression of regulator of G protein signaling-2 (RGS-2) in Bartter's/Gitelman's syndrome. A role in the control of vascular tone and implication for hypertension. J Clin Endocrinol Metab 2004 0.89
19 An abnormal gene expression of the beta-adrenergic system contributes to the pathogenesis of cardiomyopathy in cirrhotic rats. Hepatology 2008 0.88
20 Insulin generates free radicals by an NAD(P)H, phosphatidylinositol 3'-kinase-dependent mechanism in human skin fibroblasts ex vivo. Diabetes 2004 0.88
21 G-protein beta3-subunit gene 825T allele and hypertension: a longitudinal study in young grade I hypertensives. Hypertension 2003 0.87
22 Angiotensin II type 1 receptor gene polymorphism predicts development of hypertension and metabolic syndrome. Am J Hypertens 2008 0.86
23 Oxidative stress in kidney transplant patients with calcineurin inhibitor-induced hypertension: effect of ramipril. J Cardiovasc Pharmacol 2002 0.83
24 Reduced content of alpha subunit of Gq protein content in monocytes of Bartter and Gitelman syndromes: relationship with vascular hyporeactivity. Kidney Int 2002 0.83
25 Insulin generates free radicals in human fibroblasts ex vivo by a protein kinase C-dependent mechanism, which is inhibited by pravastatin. Free Radic Biol Med 2006 0.82
26 Silencing regulator of G protein signaling-2 (RGS-2) increases angiotensin II signaling: insights into hypertension from findings in Bartter's/Gitelman's syndromes. J Hypertens 2008 0.81
27 Nifedipine versus carvedilol in the treatment of de novo arterial hypertension after liver transplantation: results of a controlled clinical trial. Liver Transpl 2008 0.81
28 Genome-wide association study identifies CAMKID variants involved in blood pressure response to losartan: the SOPHIA study. Pharmacogenomics 2014 0.81
29 Angiotensin II-induced over-activation of p47phox in fibroblasts from hypertensives: which role in the enhanced ERK1/2 responsiveness to angiotensin II? J Hypertens 2005 0.80
30 Rho/Rho-kinase and C-reactive protein relationship in hypertension and atherosclerosis. Nephrol Dial Transplant 2005 0.79
31 The search for a link between inflammation and hypertension--contribution from Bartter's/Gitelman's syndromes. Nephrol Dial Transplant 2006 0.79
32 Reduced mRNA and protein content of rho guanine nucleotide exchange factor (RhoGEF) in Bartter's and Gitelman's syndromes: relevance for the pathophysiology of hypertension. Am J Hypertens 2005 0.79
33 Pseudohyperaldosteronism: pathogenetic mechanisms. Crit Rev Clin Lab Sci 2003 0.79
34 Antioxidant and antiinflammatory effect of carvedilol in mononuclear cells of hypertensive patients. Am J Med 2005 0.79
35 Outcome after acute ischemic stroke (AIS) in older patients: effects of age, neurological deficit severity and blood pressure (BP) variations. Arch Gerontol Geriatr 2010 0.78
36 RGS2 C1114G polymorphism and body weight gain in hypertensive patients. Metabolism 2008 0.78
37 Early markers of inflammation in a high angiotensin II state--results of studies in Bartter's/Gitelman's syndromes. Nephrol Dial Transplant 2006 0.78
38 Rho kinase and PAI-1 in Bartter's/Gitelman's syndromes: relationship to angiotensin II signaling. J Hypertens 2004 0.77
39 High-altitude cerebral effects: risks and mechanisms. Lancet Neurol 2009 0.77
40 An update on hypertensive emergencies and urgencies. J Cardiovasc Med (Hagerstown) 2015 0.76
41 Kidney transplant in Gitelman's syndrome. Report of the first case. J Nephrol 2003 0.76
42 Oxidative stress-related factors in Bartter's and Gitelman's syndromes: relevance for angiotensin II signalling. Nephrol Dial Transplant 2003 0.76
43 Autonomic nervous system function in chronic hypotension associated with Bartter and Gitelman syndromes. Am J Kidney Dis 2007 0.76
44 Myocardial function in Bartter's and Gitelman's syndromes. Kidney Int 2003 0.76
45 Blood pressure in acute ischemic stroke and mortality: a study with noninvasive blood pressure monitoring. Blood Press Monit 2006 0.76
46 Orthostatic hypotension and supine hypertension in primary autonomic failure. Hypertension 2005 0.75
47 Effect of manidipine on gene expression and protein level of oxidative stress-related proteins: p22phox and HO-1: relevance for antihypertensive and anti-remodeling effects. J Cardiovasc Pharmacol 2004 0.75
48 Galphai2 expression, hypertension and insulin resistance. J Hypertens 2006 0.75
49 Rho kinase inhibition and vascular protection: support from studies in Bartter and Gitelman syndrome. Arterioscler Thromb Vasc Biol 2005 0.75
50 Should travelers with hypertension adjust their medications when traveling to high altitude? High Alt Med Biol 2009 0.75
51 NADPH oxidase, superoxide overproduction and nitric oxide bioavailability in essential hypertension. J Hypertens 2005 0.75
52 L-carnitine and erythropoiesis: relationship with haeme oxygenase-1. Nephrol Dial Transplant 2005 0.75
53 Antihypertensive treatment and cognitive function: another tempest in a P pot? J Hypertens 2008 0.75
54 Insulin signaling, glucose metabolism, and the angiotensin II signaling system: studies in Bartter's/Gitelman's syndromes. Diabetes Care 2006 0.75
55 Acute mountain sickness in a subject with metabolic syndrome at high altitude. High Alt Med Biol 2008 0.75
56 Bartter's and Gitelman's syndromes: a confirm in humans of the utility of Rho kinase inhibition for cardiovascular protection. J Hypertens 2005 0.75
57 [C825T polymorphism of the GNB3 gene codifying the G-protein beta3-subunit and cardiovascular risk]. Ann Ital Med Int 2005 0.75
58 Different effect of ouabain on endothelin-1-induced extracellular signal-regulated kinase stimulation in rat heart and tail artery. J Cardiovasc Pharmacol 2003 0.75
59 Hypertension after acute ischemic stroke in older patients: effect on neurological outcome. J Am Geriatr Soc 2008 0.75
60 A pheochromocytoma with normal clonidine-suppression test: how difficult the biochemical diagnosis? Intern Emerg Med 2008 0.75
61 Effect of doxazosin on oxidative stress-related proteins in benign prostatic hyperplasia. Urol Int 2006 0.75
62 Treatment options in fibromuscular dysplasia of the renal artery: when percutaneous transluminal angioplasty is at high risk? Hypertens Res 2013 0.75